(C) 2013 Elsevier Masson SAS. All rights reserved.”
“The mitochondrial fatty acid beta-oxidation (FAO) pathway plays a crucial role in ATP production in many tissues with high-energy

demand. This Linsitinib is highlighted by the diverse and possibly severe clinical manifestations of inborn fatty acid beta-oxidation deficiencies. More than fifteen genetic FAO enzyme defects have been described to date, forming a large group of rare diseases. Inborn FAO disorders are characterized by a high genetic heterogeneity, with a variety of gene mutations resulting in complete or partial loss-of-function of the corresponding enzyme. The panel of observed phenotypes varies from multi-organ failure in the neonate with fatal outcome, up to milder late onset manifestations associated with significant disabilities. Diagnosis of FAO disorders has markedly improved over the last decades, but few treatments are available. The clinical, biochemical, and molecular analysis of these disorders

provided new, and sometimes unexpected, data on the organization and regulation of mitochondrial FAO in humans, in various Selleckchem AR-13324 tissues, and at various stages of development. This will be illustrated by examples of FAO defects affecting enzymes of long-chain fatty acid import into the mitochondria, or Lynen helix enzymes. The involvement of the transcriptional network regulating FAO gene expression, in particular the PGC-1 alpha/PPAR axis, as a target for pharmacological therapy of these genetic disorders, will also be discussed. (C) 2013 Elsevier Masson SAS. All rights reserved.”
“Background Lipoprotein(a) [Lp(a)] can influence the development and disruption of atherosclerotic plaques through its effect on lipid accumulation. The purpose of this study was STA-9090 to evaluate the relationship between serum Lp(a) levels and plaque morphology of an infarct-related lesion and non-infarct-related lesion of the coronary artery in acute myocardial infarction (AMI).Methods

and results Coronary plaque morphology was evaluated in 68 patients (age 62.1 +/- 12.1 years, mean +/- SD; men n=58, women n=10) with AMI by intravascular ultrasound with radiofrequency data analysis before coronary intervention and by 64-slice computed tomography angiography within 2 weeks. Patients were divided into a group with an Lp(a) level of 25 mg/dl or more (n=20) and a group with an Lp(a) level of less than 25 mg/dl (n=48). Intravascular ultrasound with radiofrequency data analysis identified four types of plaque components at the infarct-related lesion: fibrous, fibrofatty, dense calcium, and necrotic core. The necrotic core component was significantly larger in the group with an Lp(a) level of 25 mg/dl or more than in the group with an Lp(a) level of less than 25 mg/dl (27.6 +/- 8.0 vs. 15.7 +/- 10.0%, P=0.0001).